Picture Sino Biological Symposium Antibody Engineering Leipzig 650x100px
Organisation › Details

ImaBiotech SAS

ImaBiotech is a Contract Research Organization (CRO) with facilities in Boston (MA, USA) and Lille (Eurasanté Parc, France). The company offers innovative services and software to the pharmaceutical research sector, providing highly in vivo informative drug efficacy and toxicity evaluations during preclinical and clinical stage developments at cellular level, making better and safer drugs. Services are based on histology combined to label free molecular imaging (Quantitative Mass Spectrometry Imaging, QMSI) a technology developed and constantly improved by ImaBiotech. QMSI is a game changer for the pharmaceutical industry in all therapeutic areas. While other techniques provide global information, this molecular technique provides a deeper understanding of a drugs localization and its pharmacological effects at cellular level. This improves the interpretation of drug efficacy and toxicity, resulting in better drugs and decreasing time-to-market. *



Profile: Located in Europe (France) and North America (Cambridge, MA), ImaBiotech develops and offers new imaging technologies, applications and software (Quantinetix™, Multimaging™). In order to accelerates drug development with innovative & proprietary imaging technologies, ImaBiotech offers Mass Spectrometry Imaging Services to provide a cost-effective solution to preclinical and clinical studies. This molecular technique is used for qualitative & quantitative efficacy and toxicity evaluations of drug candidates from the whole body to cell levels.

Industry: Biotechnology

Products/Services: Biomarker discovery, target engagement, analysis of quantitative distributions of your lead compounds, toxicity studies with QMSI to identify the relation between drug, metabolites and toxicity.

Established: 2009

Employees: 20

Partners: Bruker, Prof. Ron Heern, Dr. Walter Korfmacher, Dr. Markus Stoeckli

The organisation submitted the information to [MSC] on 21 March 2016.

Period Start 2009-01-01 established
  Group ImaBiotech (Group)
Products Industry mass spectrometry software (MS software)
  Industry 2 Quantinetix™ software for quantitative MALDI imaging
Persons Person Stauber, Jonathan (ImaBiotech 201206 CEO)
  Person 2 Bonnel, David (ImaBiotech 201901 Executive Director)
Region Region Loos (Loos-lez-Lille)
  Country France
  Street 885 Avenue Eugène Avinée
  City 59120 Loos
  Tel +33-9-7044-0008
    Address record changed: 2024-01-05
Basic data Employees B: 11 to 50 (2016-03-21)
    * Document for »About Section«: ImaBiotech SAS. (1/17/19). "Press Release: OCR and ImaBiotech Initiate a Strategic Partnership to Provide in situ Drug Efficacy and Target Exposure Services in Pets with Naturally Occuring Tumors". Lille.
Record changed: 2024-03-30


Picture Sino Biological Symposium Antibody Engineering Leipzig 650x200px

More documents for ImaBiotech (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture Sino Biological Symposium Antibody Engineering Leipzig 650x200px

» top